Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Zydus Cadila gets USFDA nod to market 2 generic drugs

      Zydus Cadila gets USFDA nod to market 2 generic drugs

      Medical Dialogues Bureau1 May 2019 8:05 PM IST
      New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
      Lupin-Natco get USFDA nod to market generic hypertension drug

      Lupin-Natco get USFDA nod to market generic hypertension drug

      Medical Dialogues Bureau1 May 2019 8:05 PM IST
      New Delhi: Drug firm Lupin, in alliance with Natco Pharma, has received approval from the US health regulator to market generic Bosentan tablets used...
      Vaccine and blood thinner help drive Pfizer to quarterly earnings beat

      Vaccine and blood thinner help drive Pfizer to quarterly earnings beat

      Medical Dialogues Bureau1 May 2019 12:07 PM IST
      Pfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
      USFDA declines to approve Nabriva

      USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections

      Medical Dialogues Bureau1 May 2019 12:02 PM IST
      The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
      Ghana becomes second country to launch vital malaria vaccine

      Ghana becomes second country to launch vital malaria vaccine

      Medical Dialogues Bureau1 May 2019 10:04 AM IST
      Ghana on Tuesday rolled out the world's only proven malaria vaccine for infants as part of a landmark campaign against the deadly mosquito-borne...
      Bayer can absorb Roundup costs of 5 billion euros, but not 20 billion - Moodys

      Bayer can absorb Roundup costs of 5 billion euros, but not 20 billion - Moody's

      Medical Dialogues Bureau1 May 2019 9:04 AM IST
      BERLIN: Bayer could absorb litigation costs of up to 5 billion euros ($5.59 billion) to settle ongoing lawsuits linked to its Monsanto weed-killer...
      GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

      GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

      Medical Dialogues Bureau30 April 2019 9:15 AM IST
      New Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
      Using AI to detect mental health disorders likely to be counterproductive

      Using AI to detect mental health disorders likely to be counterproductive

      Medical Dialogues Bureau30 April 2019 9:00 AM IST
      AI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
      USFDA approves perfusion device Xvivo Perfusion System for lung transplants

      USFDA approves perfusion device Xvivo Perfusion System for lung transplants

      Medical Dialogues Bureau29 April 2019 9:00 AM IST
      The Xvivo Perfusion System works by allowing marginal quality lungs that initially failed to meet standard transplantation models to be ventilated,...
      Serdia Pharma launches nationwide campaign for angina awareness

      Serdia Pharma launches nationwide campaign for angina awareness

      Medical Dialogues Bureau28 April 2019 9:25 AM IST
      As a part of this global initiative, SERDIA Pharmaceuticals has launched a comprehensive programme in India: 'Angina Awareness India'.New Delhi:...
      Trump to keep fighting opioids

      Trump to keep fighting opioids 'until our job is done'

      Medical Dialogues Bureau28 April 2019 9:00 AM IST
      While prescription opioids initially accounted for most deaths, the epidemic is now driven by illicit heroin and fentanyl.ATLANTA: President Donald...
      Biomed writes to Health Ministry saying it can supply vaccines for Haj pilgrims

      Biomed writes to Health Ministry saying it can supply vaccines for Haj pilgrims

      Medical Dialogues Bureau27 April 2019 9:45 AM IST
      Biomed Pvt Ltd was directed to stop the manufacture, sale and distribution of all human vaccines, including the Quadrivalent Meningococcal Meningitis...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok